nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative study in patients with type 2 von Willebrand disease using 4 different platelet-dependent von Willebrand factor assays
|
Colpani, Paola |
|
|
7 |
3 |
p. |
artikel |
2 |
Catastrophic antiphospholipid syndrome in an immune thrombocytopenia patient treated with avatrombopag
|
Van de Vondel, Saartje |
|
|
7 |
3 |
p. |
artikel |
3 |
Corrigendum to ‘The Hemophilia Joint Health Score version 2.1 Validation in Adult Patients Study: A multicenter international study’ [Research and Practice in Thrombosis and Haemostasis, 6/2, (2022) e12690]
|
Minford, Adrian |
|
|
7 |
3 |
p. |
artikel |
4 |
C-reactive protein and D-dimer in cerebral vein thrombosis: Relation to clinical and imaging characteristics as well as outcomes in a French cohort study
|
Billoir, Paul |
|
|
7 |
3 |
p. |
artikel |
5 |
Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism: A Persian-speaking cohort
|
Mehdizadeh, Kasra |
|
|
7 |
3 |
p. |
artikel |
6 |
Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: A systematic review
|
Candeloro, Matteo |
|
|
7 |
3 |
p. |
artikel |
7 |
Durability of platelet response after switching to avatrombopag from eltrombopag or romiplostim in immune thrombocytopenia
|
Al-Samkari, Hanny |
|
|
7 |
3 |
p. |
artikel |
8 |
Editorial Board
|
|
|
|
7 |
3 |
p. |
artikel |
9 |
Effect of tube filling on plasma freezing for coagulation testing
|
Sinegre, Thomas |
|
|
7 |
3 |
p. |
artikel |
10 |
Evaluation of four commercial ELISAs to measure tissue factor in human plasma
|
Sachetto, Ana T.A. |
|
|
7 |
3 |
p. |
artikel |
11 |
Frailty and subsequent adverse outcomes in older patients with atrial fibrillation treated with oral anticoagulants: The Shizuoka study
|
Nishimura, Shiori |
|
|
7 |
3 |
p. |
artikel |
12 |
Hemostatic defects in congenital disorders of glycosylation
|
Pascreau, Tiffany |
|
|
7 |
3 |
p. |
artikel |
13 |
Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years
|
Weller, Susan C. |
|
|
7 |
3 |
p. |
artikel |
14 |
Issue Information
|
|
|
|
7 |
3 |
p. |
artikel |
15 |
Management of heavy menstrual bleeding in women with bleeding disorders in a tertiary care center
|
Kuthiala, Shikha |
|
|
7 |
3 |
p. |
artikel |
16 |
Mechanisms of cancer-associated thrombosis
|
Hisada, Yohei |
|
|
7 |
3 |
p. |
artikel |
17 |
Novel mechanisms of thrombo-inflammation during infection: the harmful impact of circulating histones
|
Ligi, Daniela |
|
|
7 |
3 |
p. |
artikel |
18 |
Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms
|
Lee, Christine S.M. |
|
|
7 |
3 |
p. |
artikel |
19 |
Precision antiplatelet therapy
|
Rocca, Bianca |
|
|
7 |
3 |
p. |
artikel |
20 |
Prediction of thrombosis in polycythemia vera: Development and validation of a multiple factor-based prognostic score system
|
Gu, Wenjing |
|
|
7 |
3 |
p. |
artikel |
21 |
Recanalization and outcomes after cerebral venous thrombosis: a systematic review and meta-analysis
|
Kim, Diana J. |
|
|
7 |
3 |
p. |
artikel |
22 |
Social determinants of health in pulmonary embolism management and outcome in hospitals: Insights from the United States nationwide inpatient sample
|
Farmakis, Ioannis T. |
|
|
7 |
3 |
p. |
artikel |
23 |
The “lived” experience of menstruating women commencing anticoagulants
|
Sheikh, Umber |
|
|
7 |
3 |
p. |
artikel |
24 |
Tissue factor activity of small and large extracellular vesicles in different diseases
|
Sachetto, Ana T.A. |
|
|
7 |
3 |
p. |
artikel |
25 |
Tissue factor–positive extracellular vesicles in plasma are not associated with venous thromboembolism in patients with ovarian cancer
|
Hisada, Yohei |
|
|
7 |
3 |
p. |
artikel |
26 |
Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
|
Kang, Hye-Rim |
|
|
7 |
3 |
p. |
artikel |
27 |
Treatment switch to nonacog beta pegol factor IX in hemophilia B: A Canadian cost-consequence analysis based on real-world factor IX consumption and clinical outcomes
|
Iorio, Alfonso |
|
|
7 |
3 |
p. |
artikel |
28 |
What did we learn (and did not learn) from the pediatric direct oral anticoagulant trials, and how might we better design pediatric anticoagulant trials in the future?
|
Betensky, Marisol |
|
|
7 |
3 |
p. |
artikel |